Search Results - "Hoti F"

This result is not displayed to guests.
Login for full access.

Bayesian mapping of genotype × expression interactions in quantitative and qualitative traits.

Authors: Hoti, F. Sillanpää, M. J.

Source: Heredity. Jul2006, Vol. 97 Issue 1, p4-18. 15p. 1 Diagram, 4 Charts, 6 Graphs.

Advanced backcross-QTL analysis in spring barley ( H. vulgare ssp. spontaneum) comparing a REML versus a Bayesian model in multi-environmental field trials.

Authors: Bauer, Andrea Michaela Hoti, F. von Korff, M. et al.

Source: Theoretical & Applied Genetics. Jun2009, Vol. 119 Issue 1, p105-123. 19p. 6 Charts, 2 Graphs.

Subjects: Barley, Locus (Genetics), Genetic markers, Hordeum

Geographic Terms: Israel

Modelling multi-type transmission of pneumococcal carriage in Bangladeshi families.

Authors: P. Erästö Hoti, F. Granat, S. M. et al.

Source: Epidemiology & Infection. Jun2010, Vol. 138 Issue 6, p861-872. 12p. 4 Charts, 4 Graphs.

Bayesian prediction of breeding values by accounting for genotype-by-environment interaction in self-pollinating crops.

Authors: BAUER, A. M. HOTI, F. REETZ, T. C. et al.

Source: Genetics Research; Jun2009, Vol. 91 Issue 3, p193-207, 15p

Persistence of advanced systemic pharmacological treatment of moderate‐to‐severe psoriasis among bio‐naïve patients—A retrospective register‐based cohort study in Finland and Sweden.

Authors: Tskhvarashvili, G. Aher, K. Sveide, I. et al.

Source: Journal of the European Academy of Dermatology & Venereology. 2025 Supplement, Vol. 39, p50-64. 15p.

Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmission.

Authors: Hoti F Erästö P Leino T et al.

Source: BMC Infectious Diseases. 2009, Vol. 9 Issue 1, p102-102. 1p.

Regional Assessment of Severe Hypoglycemic Coma Events in Finland.

Authors: Vattulainen, P. Mushnikov, V. Hoti, F. et al.

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA332-A332. 1p.

Patients With COPD who Initiate Roflumilast in Sweden.

Authors: Khalid, J.M. Mushnikov, V. Vattulainen, P. et al.

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA590-A590. 1p.

Entacapone did not Increase Prostate Cancer Risk or Mortality in Patients with Parkinson's Disease.

Authors: Korhonen, P. Kuoppamäki, M. Prami, T. et al.

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA393-A393. 1p.

Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study.

Authors: Langslet G Nyström T Vistisen D et al.

Source: Journal of diabetes research [J Diabetes Res] 2024 Oct 12; Vol. 2024, pp. 6142211. Date of Electronic Publication: 2024 Oct 12 (Print Publication: 2024).

Publication Type: Journal Article; Comparative Study; Multicenter Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101605237 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6753 (Electronic) NLM ISO Abbreviation: J Diabetes Res Subsets: MEDLINE

Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.

Authors: Garbe E Hoti F Schink T et al.

Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2024 Aug 21; Vol. 19, pp. 1879-1892. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).

Publication Type: Journal Article; Observational Study; Multicenter Study

Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE

Post-authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: A multi-country European study.

Authors: Schmedt N Alhamdow A Tskhvarashvili G et al.

Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Aug; Vol. 27 (8), pp. 4401-4414. Date of Electronic Publication: 2025 Jun 13.

Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

Authors: Swart KMA Baak BN Lemmens L et al.

Source: Respiratory research [Respir Res] 2023 Nov 21; Vol. 24 (1), pp. 293. Date of Electronic Publication: 2023 Nov 21.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies.

Authors: Nordon C Simons SO Marshall J et al.

Source: ERJ open research [ERJ Open Res] 2025 Jun 16; Vol. 11 (3). Date of Electronic Publication: 2025 Jun 16 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.

Authors: Vistisen D Carstensen B Elisabetta P et al.

Corporate Authors: Vistisen D Carstensen B Elisabetta P et al.

Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Aug 31; Vol. 22 (1), pp. 233. Date of Electronic Publication: 2023 Aug 31.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.

Authors: Dudukina E Szépligeti SK Karlsson P et al.

Source: Drug safety [Drug Saf] 2023 Jul; Vol. 46 (7), pp. 661-675. Date of Electronic Publication: 2023 Apr 26.

Publication Type: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study.

Authors: Arena PJ Huang K Löfling L et al.

Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 May; Vol. 32 (5), pp. 592-596. Date of Electronic Publication: 2022 Dec 29.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE; PubMed not MEDLINE

Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States.

Authors: Ehrenstein V Huang K Kahlert J et al.

Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Jun; Vol. 30 (6), pp. 758-769. Date of Electronic Publication: 2021 Jan 24.

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

Relationship of the Behavior of Older Participants with Body Composition Change: Results of the Second Wave of the Cognition of Older People, Education, Recreational Activities, Nutrition, Comorbidities, and Functional Capacity Studies (COPERNICUS).

Authors: Kujawska A López Sánchez GF Hoti F et al.

Source: Nutrients [Nutrients] 2023 Apr 11; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 11.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE